Overview
Aline De Vleminck practices practicing medicine in Brussels, Belgium.
Her clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Dementia.
She is actively involved in clinical research, co-authoring 69 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Aline De Vleminck
Is Aline De Vleminck a top-rated expert for Primary Lateral Sclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Aline De Vleminck is classified as an Experienced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Aline De Vleminck participate in research or clinical trials?
Yes. Aline De Vleminck has published 68 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Aline De Vleminck's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- DementiaMs. De Vleminck isExperienced. Learn about Dementia.
- Primary Lateral SclerosisMs. De Vleminck isExperienced. Learn about Primary Lateral Sclerosis.